The customary formulation employed to vaccinate children against diphtheria, tetanus, and pertussis, commonly referred to as whooping cough, involves the utilization of a vaccine referred to as “acellular pertussis” (aP). This particular vaccine, which was introduced in the mid-1990s, is typically administered as part of a combined vaccine regimen known as DTaP.